Skip to main content
C
CorpDigest
Search

Cardinal Health, Inc.

Healthcare Distribution / Medical DistributionFounded 1971
Reviewed by Swet Parvadiya
Company data updated: October 2026

Acquisitions

Cardinal Health Acquisitions

7

Major Deals Covered

$11.9B

Disclosed Deal Value

What are Cardinal Health's biggest acquisitions?

Cardinal Health's largest disclosed acquisition here is Patient Recovery Business from Medtronic for $6.1B in 2017. This page covers 7 major deals from 1979 to 2025, each with its price where disclosed and the reason behind it.

Major deals covered
7
Largest deal
Patient Recovery Business from Medtronic ($6.1B)
First deal
1979
Most recent
2025
CompanyYearPricePurpose
Bailey Drug Co.1979UndisclosedCardinal Health's first acquisition in pharmaceutical distribution, marking the company's pivot from food wholesaling to healthcare. Bailey Drug was a small pharmaceutical distributor in Zanesville, Ohio.
Allegiance Healthcare Corp.1999UndisclosedCardinal Health acquired Allegiance Healthcare to become a major player in the medical-surgical products market, adding manufacturing and distribution capabilities for medical and surgical supplies.
Patient Recovery Business from Medtronic2017$6.1BCardinal Health acquired the Patient Recovery business from Medtronic to expand its medical products portfolio, adding wound care, compression therapy, and patient positioning products.
Advanced Diabetes Supply Group (ADSG)2025$1.1BCardinal Health agreed in November 2024 to buy ADSG, a diabetes supplies provider, for about $1.1 billion to expand its at-Home Solutions business in direct-to-patient diabetes care such as continuous glucose monitors.
Integrated Oncology Network (ION)2024UndisclosedCardinal Health acquired ION, a network of community oncology practices, to build its specialty care platform in oncology and create integrated care networks combining drug distribution with practice management.
GI Alliance (71% stake)2024$2.8BCardinal Health bought a 71% stake in GI Alliance, the largest U.S. gastroenterology MSO, for about $2.8 billion in cash, announced in November 2024. GI Alliance operates as a platform within the Pharmaceutical and Specialty Solutions segment.
Solaris Health (via The Specialty Alliance)2025$1.9BCardinal Health provided about $1.9 billion in cash so The Specialty Alliance, its multi-specialty MSO, could acquire Solaris Health, the largest U.S. urology MSO, from Lee Equity Partners and physician owners.
What companies has Cardinal Health bought?
Major acquisitions by Cardinal Health documented here include Patient Recovery Business from Medtronic (2017), GI Alliance (71% stake) (2024), Solaris Health (via The Specialty Alliance) (2025), Advanced Diabetes Supply Group (ADSG) (2025) and Integrated Oncology Network (ION) (2024).
What is Cardinal Health's most recent acquisition?
The most recent Cardinal Health acquisition documented here is Advanced Diabetes Supply Group (ADSG), in 2025, for $1.1B.

Advanced Diabetes Supply Group (ADSG)

2025

$1.1B

Why

Cardinal Health agreed in November 2024 to buy ADSG, a diabetes supplies provider, for about $1.1 billion to expand its at-Home Solutions business in direct-to-patient diabetes care such as continuous glucose monitors.

Impact

The acquisition added significant scale to Cardinal Health's at-Home Solutions business, creating a recurring revenue stream with direct patient relationships. It positioned the company to benefit from the shift toward home-based diabetes management.

Outcome

ADSG is part of at-Home Solutions within the Other segment, which grew revenue 26% to $6.8 billion in fiscal 2026.

Source →

Solaris Health (via The Specialty Alliance)

2025

$1.9B

Why

Cardinal Health provided about $1.9 billion in cash so The Specialty Alliance, its multi-specialty MSO, could acquire Solaris Health, the largest U.S. urology MSO, from Lee Equity Partners and physician owners.

Impact

The deal gave The Specialty Alliance national scale in urology, building on earlier purchases of Urology America, Potomac Urology, and Academic Urology & Urogynecology. Cardinal Health owns about 75% of The Specialty Alliance.

Outcome

The acquisition closed on November 3, 2025.

Source →

Integrated Oncology Network (ION)

2024

Why

Cardinal Health acquired ION, a network of community oncology practices, to build its specialty care platform in oncology and create integrated care networks combining drug distribution with practice management.

Impact

The acquisition established Cardinal Health's presence in community oncology, a high-growth specialty area with significant pharmaceutical spending. It created opportunities for vertical integration between drug distribution and cancer care delivery.

Outcome

ION forms the oncology piece of Cardinal Health's specialty platform strategy, linking community oncology practices with the company's specialty distribution business.

Source →

GI Alliance (71% stake)

2024

$2.8B

Why

Cardinal Health bought a 71% stake in GI Alliance, the largest U.S. gastroenterology MSO, for about $2.8 billion in cash, announced in November 2024. GI Alliance operates as a platform within the Pharmaceutical and Specialty Solutions segment.

Impact

The deal gave Cardinal Health a large physician-facing platform in gastroenterology, a specialty with heavy use of biologic and specialty drugs.

Outcome

GI Alliance anchors Cardinal Health's practice-management strategy, alongside The Specialty Alliance in urology and other specialties.

Source →

Patient Recovery Business from Medtronic

2017

$6.1B

Why

Cardinal Health acquired the Patient Recovery business from Medtronic to expand its medical products portfolio, adding wound care, compression therapy, and patient positioning products.

Impact

The acquisition significantly expanded Cardinal Health's medical products manufacturing capabilities and added scale to the Global Medical Products and Distribution segment. It deepened the company's presence in the hospital and post-acute care markets.

Outcome

The Patient Recovery business has been integrated into Cardinal Health's medical products operations, contributing to segment revenue but facing competitive pressure from lower-cost manufacturers.

Source →

Allegiance Healthcare Corp.

1999

Why

Cardinal Health acquired Allegiance Healthcare to become a major player in the medical-surgical products market, adding manufacturing and distribution capabilities for medical and surgical supplies.

Impact

The acquisition transformed Cardinal Health from a pure pharmaceutical distributor into a diversified healthcare products company. It established the foundation for the Global Medical Products and Distribution segment and added billions in annual revenue.

Outcome

The Allegiance business became the core of what is now the Global Medical Products and Distribution segment, which has faced margin pressure from competition, inflation, and tariffs.

Source →

Bailey Drug Co.

1979

Why

Cardinal Health's first acquisition in pharmaceutical distribution, marking the company's pivot from food wholesaling to healthcare. Bailey Drug was a small pharmaceutical distributor in Zanesville, Ohio.

Impact

The acquisition established Cardinal Health's presence in pharmaceutical distribution and set the template for the company's acquisition-driven growth strategy. It provided the foundation for what would become one of the three dominant U.S. pharmaceutical wholesalers.

Outcome

Bailey Drug was fully integrated into Cardinal's operations and served as the platform for subsequent pharmaceutical distribution acquisitions throughout the 1980s.

Source →

Cardinal Health, Inc.'s Growth & Acquisition Strategy

Cardinal Health's growth plan rests on three levers. First, specialty pharmaceuticals and physician practice platforms: it bought a 71% stake in GI Alliance for about $2.8 billion (announced November 2024) and funded The Specialty Alliance's roughly $1.9 billion acquisition of urology MSO Solaris Health (completed November 2025). Second, the Other segment: Nuclear and Precision Health Solutions (radiopharmaceuticals and theranostics), at-Home Solutions (expanded with ADSG in 2025, Strive Medical, and the announced AdaptHealth diabetes business), and OptiFreight Logistics, which together grew revenue 26% to $6.8 billion in fiscal 2026. Third, improving GMPD profitability through its Cardinal Health brand products and cost actions.

How Cardinal Health, Inc. Makes Money

The business model is large, high-volume logistics divided into two segments: Pharmaceutical and Medical. In the Pharma segment, they buy billions of dollars of drugs from manufacturers (like Pfizer) and distribute them daily to tens of thousands of pharmacies and hospitals, taking a tiny markup. In the Medical segment, they actually manufacture and distribute low-cost, high-volume medical supplies (like surgical gloves, gowns, and syringes), acting as the large central supply closet for the entire American hospital system.

Cardinal Health Acquisitions FAQ

What was Cardinal Health's acquisition of Medtronic's Patient Care business in 2017?

In July 2017, Cardinal Health acquired Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses for $6.1 billion in cash, adding leading hospital brands like Covidien Kangaroo feeding tubes, Kendall wound care, and SCD compression sleeves.

Why was the acquisition of Syncor International in 2002 significant for Cardinal Health?

In January 2002, Cardinal Health acquired Syncor International Corporation for approximately $1.1 billion in stock, instantly making Cardinal Health the nation's largest operator of centralized radiopharmacies for nuclear medicine imaging.

What was the acquisition of Bindley Western Industries in 2001?

In February 2001, Cardinal Health acquired Indianapolis-based drug wholesaler Bindley Western Industries for $2.1 billion in stock, securing major distribution contracts with national drugstore chains and expanding Midwest distribution logistics.

What was Cardinal Health's acquisition of Pyxis Corporation in 1996?

In May 1996, Cardinal Health acquired Pyxis Corporation for $930 million in stock, entering the automated hospital dispensing machine and medication management market (which was later spun off with CareFusion in 2009).

What recent acquisitions expanded Cardinal Health's specialty physician practice presence in 2024?

In 2024, Cardinal Health announced major investments in specialty practice management, including agreements to acquire a majority stake in GI Alliance (gastroenterology management services) and Solaris Health (urology and specialty practice management).

What was the acquisition of The Harvard Drug Group in 2015?

In July 2015, Cardinal Health acquired generic drug distributor and repackager The Harvard Drug Group for $1.115 billion in cash, expanding its telemarketing distribution of generic pharmaceuticals and over-the-counter products to independent pharmacies.

What was the acquisition of AssuraMed in 2013?

In March 2013, Cardinal Health acquired home medical supply distributor AssuraMed (Edgepark Medical Supplies) for $2.07 billion in cash, establishing Cardinal Health at-Home Solutions to deliver diabetes, ostomy, and respiratory supplies directly to patients' homes.

How does Cardinal Health finance its multi-billion-dollar strategic acquisitions?

Cardinal Health finances strategic acquisitions through a disciplined combination of operating cash flows, low-cost investment-grade corporate bonds, and existing revolving credit facilities while maintaining strict target debt-to-EBITDA leverage ratios.

What companies has Cardinal Health acquired?

Cardinal executed aggressive acquisitions for decades to eliminate regional competitors, famously buying Bindley Western in 2001 and acquiring Medtronic's massive Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency business in 2017.

Related M&A Histories

Compare corporate acquisition records, deal values, and strategic targets

Competitor

Mckesson

View M&A Histories
Competitor

Cencora

View M&A Histories
Competitor

Cvs Health

View M&A Histories
Competitor

Unitedhealth

View M&A Histories
Competitor

Johnson And Johnson

View M&A Histories
Competitor

Labcorp

View M&A Histories

Explore Cardinal Health

Core profile pages, founders and related research hubs for this company.

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.